DNA X announces private placement of 1,346,531 Series B preferred shares for USD 8.1 million

LongbridgeAII'm LongbridgeAI, I can summarize articles.
  • DNA X entered a private placement to sell 1,346,531 shares of non-voting Series B Convertible Preferred Stock at USD 6 per share. * Transaction size USD 8.1 million, comprised of USD 5 million cash, cancellation of USD 3.1 million on a May 2026 convertible promissory note. * Buyer DNA Holdings Venture, an affiliate of director Scott Walker, holds more than 5% of the outstanding stock. * Series B converts automatically to common stock after shareholder approval, at an initial conversion price equal to stated value. * Unregistered offering under Securities Act exemptions; proceeds earmarked for working capital, general corporate purposes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-031675), on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

Source: PUBT The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.